Genomic profiling may reveal new drug targets in urothelial carcinoma
Genomic profiling may reveal new drug targets in urothelial carcinoma
Combination of abiraterone and cabazitaxel in metastatic castration-resistant prostate cancer
When and whether to conduct endocrine therapy in non-metastatic prostate cancer
High BMI beneficial in kidney cancer
Basal subtype predicts clinical benefit from neoadjuvant chemo in urothelial cancer
New approach to prostate cancer screening
Dose-escalated brachytherapy best treatment for unfavourable-risk localised prostate cancer
Combination of pazopanib and paclitaxel safe in urothelial cancer
Tackling renal cancer with a combination of autologous immunotherapy and sunitinib
Challenging results from mTOR inhibitors in metastatic clear cell renal cancer
Efficacy, tolerability and quality of life in metastatic renal cell carcinoma: Welcome and introduction
mRCC: Real-world experience: achieving efficacy beyond clinical trials